We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Search
Filters
9068 Results

Congress Abstract

Olaparib combined with radiotherapy for TNBC: 1-year toxicity report of the RADIOPARP phase 1 trial

Authors:

Pierre Loap1, Delphine Loirat2, Frédérique Berger3, Manuel Rodrigues2, Louis Bazire1, Jean-Yves Pierga2, Francesco Ricci4, Kim Cao1, Anne Vincent-Salomon5, Fatima Laki6, Cyrine Ezzili3, Anne Jochem3, Laurence Raizonville3, Veronique Mosseri3, Monia Ezzalfani3, Alain Fourquet1, Youlia Kirova1

1Institut Curie, Department of Radiation Oncology, Paris, France; 2Institut Curie, Department of Medical Oncology, Paris, France; 3Institut Curie, Department of Statistics, Paris, France; 4Institut Curie, Clinical Investigation Unit, Paris, France; 5Institut Curie, Department of Pathology, Paris, France; 6Institut Curie, Department of Surgery, Paris, France

Show Affiliations
2021
Oral
ESTRO 2021

Webcast

Radiation therapy for castrate resistant oligometastatic patients
Authors: Fabian Lohaus
2020
ESTRO 2020 - Online congress

Webcast

QA of on-line Adaptive Radiotherapy: Washington University Experience
Authors: Sasa Mutic
2019
ESTRO 38

Congress Abstract

The role of the RTT in individualised patient centric care
Authors: Nisbet|, Heather(1)*[heather.nisbet@ouh.nhs.uk];
(1)Oxford University Hospitals NHS Foundation Trust, Radiotherapy Department, Oxford, United Kingdom;
Show Affiliations
2020
ESTRO 2020

Congress Abstract

Physics treatment planning and delivery issues for FLASH Radiotherapy
Authors: VERBAKEL|, WILKO(1)*[w.verbakel@vumc.nl];
(1)AMSTERDAM UMC, RADIATION ONCOLOGY DEPARTMENT, AMSTERDAM, THE NETHERLANDS;
Show Affiliations
2020
ESTRO 2020

Congress Abstract

Interval between MRI and SRS is associated with local control in lung squamous cell brain metastasis
Authors:

Joon Wee Ho1, Luis Aznar-Garcia2, Judith Christian1, Poulam Patel3

1Nottingham University Hospitals, Oncology and Radiotherapy, Nottingham, United Kingdom; 2Nottingham University Hospitals , Oncology and Radiotherapy, Nottingham, United Kingdom; 3Nottingham University Hospitals, Oncology and Radiotherapy , Nottingham, United Kingdom

Show Affiliations
2021
Poster Discussion
ESTRO 2021

Webcast

Combining systemic therapy with hypofractionation in locally advanced NSCLC: Best of both worlds, or double-trouble?
Authors: Gerard Hanna
2018
ESTRO 37

Journal Article

Urethral and bladder dose–effect relations for late genitourinary toxicity following external beam radiotherapy for prostate cancer in the FLAME trial
Authors: Veerle H. Groen, Marcel van Schie, Nicolaas P.A. Zuithoff, Evelyn M. Monninkhof, Martina Kunze-Busch, Johannes C.J. de Boer, Jochem van der Voort van Zijp, Floris J. Pos, Robert Jan Smeenk, Karin Haustermans, Sofie Isebaert, Cédric Draulans, Tom Depuydt, Helena M. Verkooijen, Uulke A. van der Heide, Linda G.W. Kerkmeijer
2022
Radiotherapy and Oncology

Journal Article

Nonoperative versus operative approach according to the response to neoadjuvant chemoradiotherapy for rectal cancer: A prospective cohort study
Authors: Philippe P. Bulens, Lien Smets, Annelies Debucquoy, Ines Joye, André D'Hoore, Albert Wolthuis, Lynn Debrun, Jeroen Dekervel, Eric Van Cutsem, Raphaëla Dresen, Vincent Vandecaveye, Christophe M. Deroose, Xavier Sagaert, Karin Haustermans
2022
Clinical and Translational Radiation Oncology

Journal Article

GEC-ESTRO ACROP recommendations on calibration and traceability of HE HDR-PDR photon-emitting brachytherapy sources at the hospital level
Authors: Jose Perez-Calatayud, Facundo Ballester, Åsa Carlsson Tedgren, Larry A. DeWerd, Panagiotis Papagiannis, Mark J. Rivard, Frank-André Siebert, Javier Vijande
2022
Radiotherapy and Oncology
*:*